Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Gemcitabine × Head & Neck × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 7 Genitourinary 5 Breast 5 Gastrointestinal 2 Head & Neck 1 Gynecologic 1

Conditions

Nasopharyngeal Carcinoma 1

Interventions

pembrolizumab 3 Cisplatin 3 selpercatinib 2 entrectinib 2 Carboplatin 2 trametinib 1 toripalimab 1 repotrectinib 1 pralsetinib 1 penpulimab 1 larotrectinib 1 dabrafenib 1 cabozantinib 1 Gemcitabine 1 Fluorouracil 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04974398 2025-04-13

A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

Akeso

Phase 3 Active not recruiting

296 enrolled 1 FDA

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡